These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20351870)

  • 21. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward.
    Caudle KE; Keeling NJ; Klein TE; Whirl-Carrillo M; Pratt VM; Hoffman JM
    Pharmacogenomics; 2018 Jul; 19(10):847-860. PubMed ID: 29914287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies.
    Pakhomov S; McInnes BT; Lamba J; Liu Y; Melton GB; Ghodke Y; Bhise N; Lamba V; Birnbaum AK
    J Biomed Inform; 2012 Oct; 45(5):862-9. PubMed ID: 22564551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
    Pai SA; Kshirsagar N
    J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical application of pharmacogenetics: focusing on practical issues.
    Chang MT; McCarthy JJ; Shin J
    Pharmacogenomics; 2015; 16(15):1733-41. PubMed ID: 26411302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engaging Students in Pharmacogenetics: Patient Case Studies Using the PharmGKB Website.
    Mosquera AM; Aleksunes LM
    CourseSource; 2023; 10():. PubMed ID: 37476533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
    Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
    Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PharmGKB: an integrated resource of pharmacogenomic data and knowledge.
    Gong L; Owen RP; Gor W; Altman RB; Klein TE
    Curr Protoc Bioinformatics; 2008 Sep; Chapter 14():14.7.1-14.7.17. PubMed ID: 18819074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics and bioinformatics: PharmGKB.
    Thorn CF; Klein TE; Altman RB
    Pharmacogenomics; 2010 Apr; 11(4):501-5. PubMed ID: 20350130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics research network and knowledge base: 1st annual scientific meeting.
    Davis A; Long R
    Pharmacogenomics; 2001 Aug; 2(3):285-9. PubMed ID: 11939133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
    Hernandez-Boussard T; Whirl-Carrillo M; Hebert JM; Gong L; Owen R; Gong M; Gor W; Liu F; Truong C; Whaley R; Woon M; Zhou T; Altman RB; Klein TE
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D913-8. PubMed ID: 18032438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation mining experiments in the pharmacogenomics domain.
    Rinaldi F; Schneider G; Clematide S
    J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 33. PharmGKB: understanding the effects of individual genetic variants.
    Sangkuhl K; Berlin DS; Altman RB; Klein TE
    Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
    Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
    Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetic testing in psychiatry: not (quite) ready for primetime.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Nov; 52(11):13-6. PubMed ID: 25375387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ontology development for a pharmacogenetics knowledge base.
    Oliver DE; Rubin DL; Stuart JM; Hewett M; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():65-76. PubMed ID: 11928517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A SNPshot of PubMed to associate genetic variants with drugs, diseases, and adverse reactions.
    Hakenberg J; Voronov D; Nguyên VH; Liang S; Anwar S; Lumpkin B; Leaman R; Tari L; Baral C
    J Biomed Inform; 2012 Oct; 45(5):842-50. PubMed ID: 22564364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PharmGKB Drug Data Normalization with NDF-RT.
    Zhu Q; Freimuth RR; Pathak J; Chute CG
    AMIA Jt Summits Transl Sci Proc; 2013; 2013():180. PubMed ID: 24303334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics in clinical practice: considerations for testing.
    Constable S; Johnson MR; Pirmohamed M
    Expert Rev Mol Diagn; 2006 Mar; 6(2):193-205. PubMed ID: 16512779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Klein TE; Altman RB
    Pharmacogenomics J; 2004; 4(1):1. PubMed ID: 14735107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.